Portfolio Category: Current

ABL Space Systems

Ventyx Biosciences

Developing selective inhibitors of TYK2 for autoimmune diseases.

Morrow

Focused on the commercialization of spectacles with digital lens technology.

DUST Identity

Utilizes diamond crystals to enable secure identification of physical objects.

Isorg

Focused on developing an organic photodetector material (OPD) for several commercial applications.

PlanetIQ

Focused on generating higher quality atmospheric data through the design of a new satellite-deployed instrument.

ChromaCure

Focused on the development of a first-in-class oncology therapeutic.

NorthSea Therapeutics

Focused on the development of first-in-class therapeutics for NASH and other metabolic, inflammatory and fibrotic diseases.

Vascular Therapies

Focused on the development of a drug-based solution to reduce the failure rate of AV Fistulas in dialysis patients.

Trellis Bioscience

Developer of CellSpot platform to derive therapeutic antibodies directly from the human immune system.

Svelte Medical Systems

Developer of a radial drug-eluting stent platform to simplify cardiovascular stenting procedures.

Resolve Therapeutics

Focused on the development of a biologic therapy for Lupus and Sjögren’s Syndrome.